_id
6918434e3c536f8df23176fd
Ticker
WYPH
Name
WayPoint Biomedical Holdings Inc
Exchange
PINK
Address
17011 Beach Boulevard, Huntington Beach, CA, United States, 92647
Country
USA
Sector
Financial Services
Industry
Shell Companies
Currency
USD
Website
-
Description
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Last Close
0.0003
Volume
-
Current Price
0.0003
Change
0
Last Updated
2026-01-08T13:02:09.498Z
Ipo Date
-
Market Cap
16680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2022-03-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1816
Operating Income
-1816
Interest Expense
-
Pretax Income
-1816
Net Income
-1816
Eps
-0.00001908007398529834
Dividends Per Share
-
Shares Outstanding
55602852
Income Tax Expense
-
EBITDA
-1816
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
39
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
2
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
6
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2022-03-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1816
Quarters > 0 > income Statement > operating Income
-1816
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1816
Quarters > 0 > income Statement > net Income
-1816
Quarters > 0 > income Statement > eps
-0.00001908007398529834
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
95177828
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1816
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00001908007398529834
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2006-06-30
Quarters > 1 > income Statement > revenue
1513
Quarters > 1 > income Statement > cost Of Revenue
221
Quarters > 1 > income Statement > gross Profit
1292
Quarters > 1 > income Statement > operating Expenses
268082
Quarters > 1 > income Statement > operating Income
-266569
Quarters > 1 > income Statement > interest Expense
17627
Quarters > 1 > income Statement > pretax Income
-284540
Quarters > 1 > income Statement > net Income
-187796
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-96744
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-17618.572372769333
Quarters > 1 > income Statement > total Other Income Expense Net
-17971
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2471
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
2308
Quarters > 1 > balance Sheet > inventories
41805
Quarters > 1 > balance Sheet > total Current Assets
46584
Quarters > 1 > balance Sheet > property Plant Equipment
19101
Quarters > 1 > balance Sheet > total Assets
499873
Quarters > 1 > balance Sheet > payables
340659
Quarters > 1 > balance Sheet > short Term Debt
443185.64
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
835786
Quarters > 1 > balance Sheet > equity
-335913
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-187796
Quarters > 1 > cash Flow > depreciation
-56
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-143333
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
33197
Quarters > 1 > cash Flow > cash From Financing
-27305
Quarters > 1 > cash Flow > net Change In Cash
-137440
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
55.90614236424313
Quarters > 1 > ratios > ROA
-37.568742460584986
Quarters > 1 > ratios > FCF
-143333
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-94.73430270984798
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2006-03-31
Quarters > 2 > income Statement > revenue
5190
Quarters > 2 > income Statement > cost Of Revenue
8739
Quarters > 2 > income Statement > gross Profit
-3549
Quarters > 2 > income Statement > operating Expenses
191740
Quarters > 2 > income Statement > operating Income
-186550
Quarters > 2 > income Statement > interest Expense
4400
Quarters > 2 > income Statement > pretax Income
-217491
Quarters > 2 > income Statement > net Income
-217491
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-3594.412331406551
Quarters > 2 > income Statement > total Other Income Expense Net
-30941
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
139911
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
30384
Quarters > 2 > balance Sheet > inventories
26354
Quarters > 2 > balance Sheet > total Current Assets
196649
Quarters > 2 > balance Sheet > property Plant Equipment
22303
Quarters > 2 > balance Sheet > total Assets
536089
Quarters > 2 > balance Sheet > payables
14269
Quarters > 2 > balance Sheet > short Term Debt
533258.58
Quarters > 2 > balance Sheet > long Term Debt
534167
Quarters > 2 > balance Sheet > total Liabilities
728109
Quarters > 2 > balance Sheet > equity
-192020
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-217491
Quarters > 2 > cash Flow > depreciation
851
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-303425
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-33227
Quarters > 2 > cash Flow > cash From Financing
474000
Quarters > 2 > cash Flow > net Change In Cash
137348
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
113.26476408707427
Quarters > 2 > ratios > ROA
-40.569942677428564
Quarters > 2 > ratios > FCF
-303425
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-58.46339113680154
Quarters > 2 > health Score
40
Quarters > 3 > quarter
2005-12-31
Quarters > 3 > income Statement > revenue
17644
Quarters > 3 > income Statement > cost Of Revenue
21457
Quarters > 3 > income Statement > gross Profit
-3813
Quarters > 3 > income Statement > operating Expenses
229748
Quarters > 3 > income Statement > operating Income
-212104
Quarters > 3 > income Statement > interest Expense
4400
Quarters > 3 > income Statement > pretax Income
-212678
Quarters > 3 > income Statement > net Income
-212678
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-1202.131036046248
Quarters > 3 > income Statement > total Other Income Expense Net
-574
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6385
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
6188
Quarters > 3 > balance Sheet > inventories
27836
Quarters > 3 > balance Sheet > total Current Assets
40409
Quarters > 3 > balance Sheet > property Plant Equipment
23575
Quarters > 3 > balance Sheet > total Assets
66444
Quarters > 3 > balance Sheet > payables
66219
Quarters > 3 > balance Sheet > short Term Debt
278375.64
Quarters > 3 > balance Sheet > long Term Debt
234167
Quarters > 3 > balance Sheet > total Liabilities
484327
Quarters > 3 > balance Sheet > equity
-417883
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-212678
Quarters > 3 > cash Flow > depreciation
851
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-303425
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-33227
Quarters > 3 > cash Flow > cash From Financing
474000
Quarters > 3 > cash Flow > net Change In Cash
137348
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
50.89414979790994
Quarters > 3 > ratios > ROA
-320.0860875323581
Quarters > 3 > ratios > FCF
-303425
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-17.19706415778735
Quarters > 3 > health Score
40
Annuals > 0 > quarter
2005-12-31
Annuals > 0 > income Statement > revenue
29744
Annuals > 0 > income Statement > cost Of Revenue
58708
Annuals > 0 > income Statement > gross Profit
-28964
Annuals > 0 > income Statement > operating Expenses
573257
Annuals > 0 > income Statement > operating Income
-543513
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-544277
Annuals > 0 > income Statement > net Income
-544277
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-1827.3029854760623
Annuals > 0 > income Statement > total Other Income Expense Net
-764
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6385
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
6188
Annuals > 0 > balance Sheet > inventories
27836
Annuals > 0 > balance Sheet > total Current Assets
40409
Annuals > 0 > balance Sheet > property Plant Equipment
23575
Annuals > 0 > balance Sheet > total Assets
66444
Annuals > 0 > balance Sheet > payables
66219
Annuals > 0 > balance Sheet > short Term Debt
278375.64
Annuals > 0 > balance Sheet > long Term Debt
234167
Annuals > 0 > balance Sheet > total Liabilities
484327
Annuals > 0 > balance Sheet > equity
-417883
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-544277
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
0
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
0
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
0
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
130.24626510291156
Annuals > 0 > ratios > ROA
-819.151465896093
Annuals > 0 > ratios > FCF
0
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
39
Annuals > 1 > quarter
2004-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
8531
Annuals > 1 > income Statement > gross Profit
-8531
Annuals > 1 > income Statement > operating Expenses
149434
Annuals > 1 > income Statement > operating Income
-149434
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-149589
Annuals > 1 > income Statement > net Income
-149589
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-155
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
120
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
120
Annuals > 1 > balance Sheet > property Plant Equipment
12047
Annuals > 1 > balance Sheet > total Assets
14627
Annuals > 1 > balance Sheet > payables
4677
Annuals > 1 > balance Sheet > short Term Debt
132617.62
Annuals > 1 > balance Sheet > long Term Debt
70000
Annuals > 1 > balance Sheet > total Liabilities
164216
Annuals > 1 > balance Sheet > equity
-149589
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-149589
Annuals > 1 > cash Flow > depreciation
2008
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-88244
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
0
Annuals > 1 > cash Flow > cash From Financing
88364
Annuals > 1 > cash Flow > net Change In Cash
120
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
100
Annuals > 1 > ratios > ROA
-1022.690914063034
Annuals > 1 > ratios > FCF
-88244
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
41
Valuation > metrics > PE
-0.00001908007398529834
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-30
Prev Risks > 1
-140
Prev Risks > 2
-163
Prev Liquidities > 0
10
Prev Liquidities > 1
26
Prev Liquidities > 2
12
Updated At
2026-01-20T22:50:29.728Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-06-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-03-31
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-09-30
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-06-30
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-03-31
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2021-12-31
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-09-30
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-06-30
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-03-31
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2020-12-31
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-09-30
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-06-30
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-03-31
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2022-03-31)
Health Score
* Institutions hold a combined 0.00% of the total shares of WayPoint Biomedical Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2022-03-31)
(Last Updated 2022-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.